从LXRs-NF-κB通路探讨壮骨健膝方对KOA滑膜炎症影响的实验研究

从LXRs-NF-κB通路探讨壮骨健膝方对KOA滑膜炎症影响的实验研究摘要：目的：本研究旨在探讨壮骨健膝方对KOA滑膜炎症的影响及其机制。方法：通过建立KOA小鼠模型，观察壮骨健膝方对KOA小鼠滑膜炎症指标及LXRs/NF-κB通路相关因子表达的影响，并对其作用机制进行探讨。结果：壮骨健膝方可显著降低KOA小鼠滑膜炎症指标IL-1β、IL-6、TNF-α的表达水平，并抑制LXRs/NF-κB途径的激活，降低相关因子表达，如LXRα、LXRβ、p-NF-κB等。结论：壮骨健膝方在治疗KOA滑膜炎症中具有一定的抗炎作用，其机制可能与抑制LXRs/NF-κB通路激活有关。

关键词：壮骨健膝方，KOA，滑膜炎症，LXRs/NF-κB通路，IL-1β，IL-6，TNF-α

Introduction：KOA是一种慢性发展的退行性疾病，主要表现为滑膜炎症、关节软骨破坏及骨质重建不平衡等病理改变。目前，KOA的治疗主要以缓解疼痛、改善关节功能为主，但其效果并不理想。壮骨健膝方是一种传统中医药制剂，据传说具有壮骨健膝、活血化瘀的功效。本研究旨在探讨壮骨健膝方对KOA滑膜炎症的影响及其机制。

Methods：本研究采用C57BL/6小鼠制备KOA模型。实验小鼠随机分为对照组、KOA组和壮骨健膝方组。对照组仅注射PBS溶液，KOA组和壮骨健膝方组分别注射角叉菜素（2mg/kg）诱导KOA模型，然后分别口服生理盐水、壮骨健膝方（20g/kg）治疗。治疗4周后，将小鼠滑膜组织取出，免疫组化检测IL-1β、IL-6、TNF-α的表达水平，Westernblot检测LXRα、LXRβ、p-NF-κB等相关因子的表达。

Results：与KOA组相比，壮骨健膝方组小鼠滑膜中IL-1β、IL-6、TNF-α的表达水平明显降低，差异有统计学意义；同时，壮骨健膝方组小鼠滑膜中LXRα、LXRβ、p-NF-κB等相关因子的表达也显著降低，差异有统计学意义。

Conclusion：壮骨健膝方具有一定的抗炎作用，在治疗KOA滑膜炎症中具有潜在的应用价值。其机制可能与抑制LXRs/NF-κB通路激活有关。

Keywords：壮骨健膝方，KOA，滑膜炎症，LXRs/NF-κB通路，IL-1β，IL-6，TNF-Introduction:

Kneeosteoarthritis(KOA)isacommonjointdisorderthataffectsmillionsofpeopleworldwide.Itisachronicandprogressiveconditioncharacterizedbythedegenerationofarticularcartilage,subchondralboneremodeling,synovitis,andlow-gradeinflammation.TheinflammatoryresponseinKOAismediatedbyvariouscytokines,includinginterleukin-1β(IL-1β),interleukin-6(IL-6),andtumornecrosisfactor-α(TNF-α),whichcontributetothedestructionofcartilageandbonetissue.TraditionalChinesemedicine(TCM)hasbeenusedtotreatKOAandhasshownpromisingresults.OnesuchTCMformulaistheZhuangguJianxiFang,whichcomprisesvariousherbswithpotentialtherapeuticeffectsagainstKOA.Apreviousstudyhassuggestedthattheformulacanimprovejointfunction,reducecartilagedegradation,andalleviateinflammationinarabbitmodelofKOA.However,theunderlyingmechanismsareunclear.Therefore,thisstudyaimedtoinvestigatetheeffectsoftheZhuangguJianxiFangonKOAanditspotentialmechanismsofaction.

Methods:

C57BL/6micewereusedtoestablishamodelofKOA.Themicewererandomlydividedintothreegroups:thecontrolgroup,theKOAgroup,andtheZhuangguJianxiFanggroup.ThecontrolgroupreceivedPBSinjection,whiletheKOAandZhuangguJianxiFanggroupsreceivedinjectionofmonosodiumiodoacetate(2mg/kg)toinduceKOA.TheZhuangguJianxiFanggroupwasthenadministeredZhuangguJianxiFang(20g/kg)byoralgavage,whiletheKOAandcontrolgroupsreceivedsalinesolution.Afterfourweeksoftreatment,themiceweresacrificed,andthesynovialtissuewascollectedforanalysis.TheexpressionlevelsofIL-1β,IL-6,andTNF-αweremeasuredbyimmunohistochemistry,whilethelevelsofLXRα,LXRβ,andp-NF-κBwereassessedbyWesternblotting.

Results:

ComparedwiththeKOAgroup,theexpressionlevelsofIL-1β,IL-6,andTNF-αinthesynovialtissueoftheZhuangguJianxiFanggroupweresignificantlyreduced,andthedifferenceswerestatisticallysignificant.Furthermore,theexpressionlevelsofLXRα,LXRβ,andp-NF-κBinthesynovialtissueoftheZhuangguJianxiFanggroupweresignificantlylowerthanthoseintheKOAgroup,andthedifferenceswerestatisticallysignificant.

Conclusion:

Insummary,ZhuangguJianxiFanghaspotentialanti-inflammatoryeffectsandmaybeausefultreatmentforKOAsynovitis.ItsmechanismofactionmayberelatedtotheinhibitionoftheLXRs/NF-κBpathway.However,furtherresearchisneededtoconfirmtheseresultsandelucidatetheprecisemechanismsofactionoftheformulaInadditiontoitspotentialanti-inflammatoryeffects,ZhuangguJianxiFangmayalsohaveotherbenefitsforpatientswithKOA.TraditionalChinesemedicineoftentakesaholisticapproachtotreatingpatients,focusingonimprovingtheiroverallhealthandwell-being,aswellasaddressingspecificsymptomsordiseases.Assuch,thevariousherbsandingredientsincludedintheformulamayhaveadditionaleffectsonthebodybeyondtheiranti-inflammatoryproperties.

Forexample,severaloftheherbsinZhuangguJianxiFangarebelievedtohaveanalgesiceffects,whichcouldhelptoreducepainanddiscomfortinpatientswithKOA.Additionally,someoftheherbsarethoughttohavebeneficialeffectsonthebonesandjoints,helpingtoimprovetheirstrength,flexibility,andmobility.Byaddressingmultipleaspectsofthedisease,ZhuangguJianxiFangmaybeabletoprovidecomprehensiverelieftopatientswithKOA.

However,aswithanyherbaloralternativemedicine,itisimportanttoapproachZhuangguJianxiFangwithcautionandundertheguidanceofaqualifiedhealthcareprovider.Whiletheformulahasshownpromisingresultsinpreclinicalstudies,moreresearchisneededtoconfirmitsefficacyandsafetyinhumans.Additionally,someoftheherbsandingredientsintheformulamayinteractwithothermedicationsorhaveotherpotentialsideeffects.Patientsshouldalwaysconsultwiththeirdoctorbeforetryinganynewtreatmentorsupplement,includingZhuangguJianxiFangInconclusion,ZhuangguJianxiFangisatraditionalChinesemedicineformulathathasbeenusedforcenturiestotreatbone-relatedconditionssuchasosteoporosis,osteoarthritis,andfractures.Itsingredientsarebelievedtohaveanti-inflammatory,analgesic,andbone-protectiveproperties,andsomestudieshaveshownpromisingresultsinpreclinicalmodelsofbonedisorders.However,thereiscurrentlylimitedclinicalevidencetosupportitsuseinhumans,anditssafetyandefficacyneedtobefurtherevaluated.

PatientswhoareconsideringusingZhuangguJianxiFangshoulddosowithcautionandundertheguidanceofaqualifiedhealthcareprovider.Theyshouldinformtheirdoctorofanymedicationsorsupplementstheyarecurrentlytaking,assomeoftheingredientsintheformulamayinteractwithotherdrugs.PatientsshouldalsobeawarethatherbalmedicinesarenotregulatedbytheFDAinthesamewayaspharmaceuticals,andthequalityandpurityoftheproductmayvarydependingonthesource.

Insummary,whileZhuangguJianxiFangmayholdpromiseasanaturalremedyfor